Analysts think BSGM stock price could increase by 1172%
Jun 14, 2024, 6:28 AM
0.00%
What does BSGM do
BioSig Technologies, Inc., a medical technology company based in Westport, Connecticut, develops the PURE EP System, a non-invasive device enhancing signal clarity for cardiac arrhythmia treatment. Launched after their 2014 IPO, this system addresses issues like environmental noise and signal saturation to improve the accuracy and efficiency of cardiac catheter ablation procedures.
3 analysts think BSGM stock price will increase by 1172.35%. The current median analyst target is $6.12 compared to a current stock price of $0.48. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.